INBS — INTELLIGENT BIO SOLUTIONS INC.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1725430 ·
Last close
$1.56
Market Cap
$5.17M
52W High
$24.90
52W Low
$1.35
ADV30
44,248
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 1,391,835 | 758,004 | -2,682,747 | -2,658,302 | 13,621,675 | 5,929,871 | 6,269,147 |
| Jun 2026 | 1,145,802 | 536,583 | -3,964,307 | -3,907,667 | 11,941,836 | 3,992,312 | 6,651,010 |
| Mar 2026 | 1,060,802 | 535,381 | -2,941,901 | -2,862,712 | 14,862,792 | 6,862,204 | 6,111,476 |
| Dec 2025 | 896,774 | 459,739 | -2,608,591 | -2,677,590 | 17,653,042 | 740,371 | 6,763,231 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-11,927,222
Investing CF
$-85,573
Financing CF
$14,983,706
CapEx
$-361,535
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-12.53
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-74,964,040
Inventory
$418,577
Receivables
$1,674,493
ST Investments
—
EBIT TTM
$-12,401,018
Pretax Income TTM
$-12,468,672
Interest Exp TTM
$67,654
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$4,495,213
EBITDA
$-11,098,566
Free Cash Flow
$-6,795,072
Enterprise Value
$1,465,992
Total Cash
$5,929,871
Total Debt
$1,788,432
Shares Out
3,316,803
Trailing EPS
$-8.44
Book Value
$2.29
ROE
-225.3%
ROA
-64.7%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 4,215,175 | -12,309,530 | -12,430,975 | 11,941,836 | 6,651,010 | 5,510,835 | -11,927,222 |
| Jun 2025 | 3,052,532 | -10,459,096 | -10,568,733 | 8,249,786 | 5,435,962 | 2,996,136 | -9,677,313 |
| Jun 2024 | 3,111,781 | -10,283,174 | -10,156,759 | 13,778,863 | 5,595,672 | 8,329,350 | -9,571,569 |
| Jun 2023 | 1,256,872 | -8,436,563 | -10,631,720 | 10,354,612 | 6,667,614 | 3,798,984 | -7,377,378 |
| Jun 2022 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$4,215,175
NetIncome TTM
$-12,430,975
OpCashFlow TTM
—
Assets (Latest)
$14,862,792
Forward EPS
$0.35
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| WOK | WORK Medical Technology Group LTD | $5.26M | $1.19 | — |
| IVF | INVO Fertility, Inc. | $5.47M | $2.18 | — |
| USAQ | QHSLab, Inc. | $5.52M | $0.37 | — |
| MHUAF | Meihua International Medical Technologies Co., Ltd. | $4.71M | $5.50 | — |
| NDRA | ENDRA Life Sciences Inc. | $5.88M | $3.92 | — |
News headlines (Yahoo Finance, 1h cache)
Intelligent Bio Solutions Reports Record Fiscal First Quarter 2027 Revenue of $1.39 Million, Marking Sixth Consecutive Quarter of Year-Over-Year Growth
2026-11-10 13:30 · Yahoo
Intelligent Bio Solutions to Present at the Webull Biotech Webinar on November 12
2026-11-04 13:30 · Yahoo
Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance
2026-09-09 12:30 · Yahoo
Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission
2026-09-01 12:31 · Yahoo
Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System
2026-08-11 12:30 · Yahoo
Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry
2026-07-23 12:30 · Yahoo
Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market
2026-07-21 12:30 · Yahoo
Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year
2026-05-13 12:30 · Yahoo
Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18
2026-06-04 12:30 · Yahoo
Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission
2026-06-02 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.